A Phase 2 Study of Poziotinib in Patients with HER2-Positive Metastatic Breast Cancer (MBC) Who Have Received Prior HER2 Regimens for MBC.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/16 → 1/1/20

Funding

  • Spectrum Pharmaceuticals, Inc